Yubo International Biotech Ltd (YBGJ) stock
Close on Oct 16, 2026Market cap $886.19KP/E –Yield –
Yubo International Biotech Ltd reported revenue of $12.35K for the twelve months to Jun 30, 2026. At the latest close the market valued the company at $886.19K.
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $886.19K
- P/E ratio
- –
- Price to sales
- 71.74
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Revenue
- $12.35K
- Net income
- -$1.01M
- EPS, diluted
- $0.00
- Book value per share
- -$0.02
- Diluted shares
- 170M
Trading
- Previous close
- $0.01
- Open
- $0.01
- Day's range
- $0.01 – $0.01
- Volume
- 0
Market cap history
Month-end market cap since 2021, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Oct 16, 2026. The S&P 500 is measured by the SPY fund.
| Period | YBGJ | S&P 500 | Difference | YBGJ per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -1.9% | +1.5% | −3.4 pts | ||
| 3 months | -65.1% | +1.9% | −67.0 pts | ||
| Year to date | -58.1% | +12.8% | −70.9 pts | ||
| 1 year | -61.8% | +16.8% | −78.5 pts | ||
| 3 years | -99.0% | +81.5% | −180.5 pts | -78.7% | +22.0% |
| 5 years | -98.9% | +83.0% | −181.9 pts | -59.2% | +12.8% |
Fifteen years at a glance
Fiscal years 2011 to 2026 and trailing twelve months, USD
Revenue
Gross profit
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases Yubo International Biotech filed with the SEC as exhibits to Form 8-K or 6-K
- Update
- Update
- Update
About Yubo International Biotech
Electromedical & Electrotherapeutic Apparatus
The company is a biotechnology enterprise that focuses on the research, development, and commercial application of endometrial stem cells. Through its Chinese operating affiliate, it markets various consumer goods under the VIVCELL brand name, including skincare, hair care, respiratory healthcare products, healthy beverages, and personal care items for men and women. In addition to physical goods, the business provides specialized stem cell solutions such as cell testing and health management consulting. Its customer base consists of individual consumers who purchase its personal healthcare items and clients who utilize its diagnostic and wellness advisory services.
Company profile, executives and historyYubo International Biotech stock: common questions
What is Yubo International Biotech's stock price?
YBGJ closed at $0.01 on Oct 16, 2026, up 0.00% on the day.
What is Yubo International Biotech's market cap?
Yubo International Biotech was worth $886.19K at the close on Oct 16, 2026: the share price times the diluted shares outstanding.
What is YBGJ's P/E ratio?
Yubo International Biotech lost money over the twelve months to Jun 30, 2026 (diluted EPS $0.00), so it has no meaningful P/E ratio.
How much revenue does Yubo International Biotech make?
Yubo International Biotech reported revenue of $12.35K for the twelve months to Jun 30, 2026.
Does Yubo International Biotech pay a dividend?
No. Yubo International Biotech has not paid a cash dividend over the last twelve months.
How has YBGJ stock performed over the past year?
Including dividends, YBGJ returned -61.8% over the past year, against +16.8% for the S&P 500.
Who are Yubo International Biotech's competitors?
Companies most similar to Yubo International Biotech by business, industry and size include CUPR, ITOC, NXL, VRAX, GIPL.
See a number that looks wrong?